22nd Jul 2020 11:24
Scancell Holdings PLC - cancer treatment developer - To raise GBP15 million via share subscription, placing, open offer and loan notes issue. To issue 90.9 million shares under subscription pact at 5.5 pence each, raising GBP5 million. Placing and open offer to raise GBP4 million. Convertible loan note issue to raise GBP6 million. Proceeds to be used for strengthening balance sheet, support clinical trials for Modi-1 Phase 1/2 and SCIB1 Phase 2; and continue initial Covid-19 vaccine development.
Current stock price: 7.25 pence for GBP33.7 million market capitalisation
Year-to-date change: unchanged
By Tapan Panchal; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Scancell Holdings